RPGLIFE
Rpg Life Sciences Limited
Each stock's 10,000-path forecast, rendered as light.
Rpg Life Sciences Limited (RPGLIFE) Stock Analysis & Case Study
Is RPGLIFE a good buy? The data-driven verdict.
Rpg Life Sciences Limited (RPGLIFE) trades at ₹2,661,on the numbers it worth a closer look, a Downstox Snapshot Score of 58/100.
On the numbers, Rpg Life Sciences Limited (RPGLIFE) worth a closer look, a Downstox Snapshot Score of 58/100, weighing premium at 37.7× earnings, ROE of 19.3%, a 54% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
RPGLIFE fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How RPGLIFE ranks against the 2,373 companies in our screener
- RPGLIFE's market cap of 4,402 Cr ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's book value of ₹366 ranks in the 85th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's promoter holding of 73.0% ranks in the 83rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's 3-year profit (PAT) growth of 31.0% ranks in the 70th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's 3-year revenue growth of 31.0% ranks in the 86th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's debt-to-equity ratio of 0.03x is lower than 90% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is RPGLIFE overvalued? RPGLIFE P/E vs peers
RPGLIFE trades at 37.7× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
RPGLIFE share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of RPGLIFE history (19%/yr drift, 42%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| RPGLIFE 2027 | ₹1,595 | ₹2,775 | ₹4,826 | +4% |
| RPGLIFE 2028 | ₹1,321 | ₹2,893 | ₹6,335 | +9% |
| RPGLIFE 2029 | ₹1,185 | ₹3,016 | ₹7,675 | +13% |
| RPGLIFE 2030 | ₹1,053 | ₹3,144 | ₹9,392 | +18% |
| RPGLIFE 2031 | ₹966 | ₹3,278 | ₹11,124 | +23% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability RPGLIFE goes up, or doubles?
The bull case for RPGLIFE
- RPGLIFE's return on equity of 19.3% ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RPGLIFE's return on capital employed of 25.7% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹7,675.
The bear case & risks
- RPGLIFE's P/E of 37.7x is lower than 36% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,185.
RPGLIFE volatility & expected range, how bumpy is the ride?
Over the last 9.8 years RPGLIFE compounded at 19%/year with annualized volatility of 42%. That volatility implies a 1-year 80% range of ₹1,595-₹4,826, the honest backbone behind any single price target.
RPGLIFE price forecast, the full 60-month probability fan
RPGLIFE price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds RPGLIFE hits common targets within the simulated horizon?
Full multi-horizon detail on the RPGLIFE price target & forecast page.
RPGLIFE Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. RPGLIFE scores 6/8, mixed financial health.
RPGLIFE MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy RPGLIFE with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 34.13% | 2.9× |
| Groww | 34.33% | 2.9× |
| DhanCHEAPEST | 34.13% | 2.9× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 34.49% | 2.9× |
| Pocketful | 34.46% | 2.9× |
| Fyers | 50.00% | 2.0× |
| Anand Rathi | 34.13% | 2.9× |
| Bajaj Broking | 40.00% | 2.5× |
| Share India | 34.28% | 2.9× |
Compare every broker on the RPGLIFE MTF page.
About Rpg Life Sciences Limited: sector, index & market-cap context
Rpg Life Sciences Limited (RPGLIFE) is a small-cap NSE-listed company, with a market capitalisation of ₹4,402 Cr. See more stocks on our screener.
How the RPGLIFE Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Rpg Life Sciences Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
RPGLIFE analysis, FAQs
Is Rpg Life Sciences Limited (RPGLIFE) a good buy?
On the numbers, Rpg Life Sciences Limited (RPGLIFE) worth a closer look, a Downstox Snapshot Score of 58/100, weighing premium at 37.7× earnings, ROE of 19.3%, a 54% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is RPGLIFE overvalued or undervalued?
RPGLIFE trades at 37.7× earnings, premium versus the ~22× long-run Nifty average.
What is the RPGLIFE share price target for 2031?
RPGLIFE's probability-weighted 2031 median target is ₹3,278, with an 80% range of ₹966-₹11,124 (10,000-path Monte-Carlo).
What is the probability RPGLIFE doubles in 5 years?
The modelled probability of RPGLIFE reaching ₹5,323 (2×) within 5 years is 31%.
What is the bull case for RPGLIFE?
RPGLIFE's return on equity of 19.3% ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. RPGLIFE's return on capital employed of 25.7% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in RPGLIFE?
RPGLIFE's P/E of 37.7x is lower than 36% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.